September 24th, 2015

Rational Drug Pricing

Economics & Politics

Global Health

Drug pricing has taken center stage in U.S. politics, and it’s high time that it should. The soaring prices for drugs like Sovaldi ($1,000 a pill) and the recent hike of Deraprim from $13.50 to $750 a pill after the supplier was bought by a shady hedge-fund manager, have caused white-hot fury in the public. Corporate lobbyists and their friends in the media spout free-market platitudes about why the sky-high prices are necessary to promote innovation. It’s time for a serious understanding of the policy issues.

Read more at The Huffington Post or download the PDF here.

 

Related Articles:

Comments

Previous post:

Next post: